Counselors in Chula Vista, CA Accepting Medicare

532 Counselors found. Showing 101 - 120

Patricia Espalin Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1180 3rd Ave, Ste C 3, Chula Vista, CA 91911 Phone: 619-691-8164

Jasmin Reham M Alfonso Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1161 Bay Blvd Ste B, Chula Vista, CA 91911 Phone: 619-585-7686

Brianda M Chavez Counselor Medicare: Not Enrolled in Medicare Practice Location: 730 Medical Center Ct, Chula Vista, CA 91911 Phone: 619-254-8740

Virginia Lucero Counselor - Pastoral Medicare: Not Enrolled in Medicare Practice Location: 285 Moss St Unit 5, Chula Vista, CA 91911 Phone: 619-253-7972

Mrs. Lina Solash Silva-cestero Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1155 Third Ave, Chula Vista, CA 91911 Phone: 619-498-8260    Fax: 619-498-8265

Giovanni Curcio Counselor Medicare: Not Enrolled in Medicare Practice Location: 637 3rd Ave, Suite I, Chula Vista, CA 91910 Phone: 619-889-4591

Elaine Mills Counselor Medicare: Not Enrolled in Medicare Practice Location: 730 Medical Center Ct, Chula Vista, CA 91911 Phone: 619-397-4330

Shahrezad Chiha Counselor Medicare: Medicare Enrolled Practice Location: 730 Medical Center Ct, Chula Vista, CA 91911 Phone: 619-591-5740

Rebekah Grace Schuringa Swanson Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1180 3rd Ave Ste C3, Chula Vista, CA 91911 Phone: 619-691-8164

Atzimba Servin Counselor Medicare: Not Enrolled in Medicare Practice Location: 730 Medical Center Ct, Chula Vista, CA 91911 Phone: 619-397-6933

Mr. Harold David Tynes Counselor Medicare: Not Enrolled in Medicare Practice Location: 1180 3rd Ave, Suite C-3, Chula Vista, CA 91911 Phone: 619-691-8164    Fax: 619-426-2359

Sarah Nicole Hershman Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2429 Fenton St, Chula Vista, CA 91914 Phone: 619-502-0088

Ruthann Weber Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1180 Third Ave Ste C3, Chula Vista, CA 91911 Phone: 619-745-6926

Mrs. Rosalinda Barba, MASTERS Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 835 3rd Ave Ste C, Chula Vista, CA 91911 Phone: 619-827-4329

Carlos Alberto Agundez Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 73 N 2nd Ave Ste B, Chula Vista, CA 91910 Phone: 619-426-4801

Lamont Long Counselor Medicare: Not Enrolled in Medicare Practice Location: 730 Medical Center Ct, Chula Vista, CA 91911 Phone: 619-397-6978

Hannah Mae Zimmerman Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 430 F St, Chula Vista, CA 91910 Phone: 619-420-3620

Miss Ianne Castro, M.S Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 730 Medical Center Ct, Chula Vista, CA 91911 Phone: 619-591-5740

Ifeoma Chime, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1161 Bay Blvd Ste B, Chula Vista, CA 91911 Phone: 619-585-7686

Mrs. Wendy Naomi Hanks, SUDRC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 629 Third Ave Ste C, Chula Vista, CA 91910 Phone: 619-691-1045

News Archive

AVEO receives EMA orphan medicinal product designation for tivozanib

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced it has received orphan medicinal product designation for tivozanib (N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate), its oral, triple VEGF receptor inhibitor, for the treatment of renal cell carcinoma by the European Medicines Agency (EMA).

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

BlueGenics aims to discover new drugs from deep sea to combat osteoporosis

Searching for substances from the deep sea to combat osteoporosis and other human common diseases is one of the objectives of the new European research project "BlueGenics" which has received funding of EUR 6 million from the European Commission.

Majority of tonsil surgery in children performed during summer vacation

Scheduling tonsils to be removed figures into many parents' itineraries for their childrens' summer vacation, right up there with summer camp stays and family reunions. An estimated 500,000 children have the procedure each year.

Integrating pharmacists into GP practices can optimize treatment plans in primary care

Research undertaken by RCSI University of Medicine and Health Sciences suggests that integrating pharmacists into general practice (GP) teams facilitates collaboration to optimize treatment plans for patients with long-term medical needs and alleviate pressures on GP practices.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3
• 4
• 5
• 6(current)
• 7
• 8
• 9
• 10
• 11
• »